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Abstract
Numerous studies have reported on the positive effects of silicon (Si) on bone
metabolism, particularly on the stimulatory effects of Si on osteoblast cells and on
bone formation. Inhibitory effects of Si on osteoclast formation and bone resorp-
tion have also been demonstrated in vitro and are suggested to be mediated indi-
rectly via stromal and osteoblast cells. Direct effects of Si on osteoclasts have been
less studied and mostly using soluble Si, but no characterisation of the Si treatment
solutions are provided. The aims of the present study were to (a) further investigate
the direct inhibitory effects of Si on osteoclastogenesis in RANKL-stimulated
RAW264.7 cells, (b) determine at what stage during osteoclastogenesis Si acts
upon, and (c) determine if these effects can be attributed to the biologically rele-
vant soluble orthosilicic acid specie. Our results demonstrate that silicon, at
50 μg/ml (or 1.8 mM), does not affect cell viability but directly inhibits the forma-
tion of TRAP+ multinucleated cells and the expression of osteoclast phenotypic
genes in RAW264.7 cells. The inhibitory effect of Si was clearly associated with the
early stages (first 24 hr) of osteoclastogenesis. Moreover, these effects can be
attributed to the soluble orthosilicic acid specie.
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1 | INTRODUCTION
Impaired bone metabolism and remodelling, due to age or disease,
may affect healing and reconstruction of bone after pathologies or
traumatic injuries. Positive effects on bone by dietary components,
such as calcium and vitamin D, are well documented. Along the same
lines, there is increasing interest in other nutritional factors for opti-
mal skeletal health.1 In 1970s, animal experiments demonstrated the
potential importance of silicon (Si) in skeletal and connective tissue
development and growth.2,3 Although the highly dramatic effects
reported in these studies have not been since replicated, there are
accumulating evidence for positive beneficial effects of Si on bone
metabolism.4-9 Silicon is ubiquitous in nature and is found combined
with oxygen in the form of silica/silicates.10,11 Weathering of rocks
release soluble orthosilicic acid (OSA, Si[OH]4, monomeric silica) into
natural waters and drinking waters.11 Indeed, orthosilicic acid is the
predominant Si specie in aqueous solutions with Si concentrations
<56 μg/ml. At concentrations >56 μg/ml, Si(OH)4 starts to polymerise
(auto condense) to form polymers that have reduced solubility and
bioavailability.11
Dietary Si is the main source of Si exposure for the general popu-
lation. Orthosilicic acid is the only known Si specie that is readily
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absorbed by humans from the diet.10 Plant based diets and beverages
accounts for the main dietary sources of exposure to Si.12 In food, Si
generally exists as polymers of different complexities that require
hydrolysis to OSA in the gastrointestinal tract prior to intestinal
uptake.13 The amount of bioavailable Si in food therefore varies
depending on the complexity of the polymers present and other die-
tary components.13 Upon gastrointestinal uptake, OSA is readily
absorbed into blood and excreted in urine.13 In healthy non-pregnant
humans, fasting serum Si concentration is approximately 0.2 mg/L and
24-hr urinary Si excretion is approximately 8 mg Si/day.14-16 The
physiological role of Si (OSA) in humans and other mammals is yet to
be established. The recent identification of transport mechanisms for
Si (OSA) in mammals suggests some form of control of Si homeostasis
and thereby implies an important role for Si in mammals.17,18
Silicon is also a common component of bone graft materials such
as Bio-Oss (from bovine bone) and Bioglass (synthetic) that are used
in the reconstruction of craniofacial and dentoalveolar bone
defects.19,20 The amount of Si in Bio-Oss is batch-dependent, which
may reflect the variability in the animal's exposure to dietary Si.19 Bio-
glass 45S5 with the composition of 45% SiO2, 25% Na20, 27% CaO,
and 3% P2O5 consists of small glass particles that are gradually
resorbed and replaced by bone at the reconstruction site.20,21 In cell
culture medium, Bio-Oss and bioactive glasses release significant
amounts of Si (up to 350 μg/ml), which suggests high levels of Si are
released at the site of implantation in bone reconstruction.19,20,22
However, it is not known what form of Si (soluble OSA or particulate
Si) is released from the biomaterials into the cell culture medium. As
Bio-Oss and bioactive glass also change the levels of calcium and
phosphate in the cell culture medium, in vitro cell culture studies have
been carried out to investigate the effects of Si alone on bone
cells.22-24 The majority of studies investigating the impact of Si on
bone metabolism have focused on the widely demonstrated
favourable osteogenic response. Silicon, in the same range of concen-
trations (15–20 μg/ml) that are released from Bioglass 45S5, increases
the expression of bone formation markers, extracellular matrix synthe-
sis, and the formation of mineralised nodules in human foetal osteo-
blasts.25 Physiological concentrations of Si (0.3–0.6 μg/ml) also
increases osteogenic differentiation in cultured mouse and human
osteoblast-like cells, and in human mesenchymal stem cells.23,24,26
There are only a few studies demonstrating the effect of Si on osteo-
clasts and bone resorption. Silica/silicate increases the expression of
osteoprotegerin in SaOS-2 osteosarcoma cells and inhibits
osteoclastogenesis in a co-culture system with receptor activator of
nuclear factor κ-B ligand (RANKL) stimulated RAW264.7 cells.27 Sili-
con also inhibits the expression of macrophage colony stimulating fac-
tor (MCS-F) and RANKL in cultured human mesenchymal stem cells.24
These findings support the hypothesis that stromal/osteoblast cells
may mediate the inhibitory effects of Si on osteoclastogenesis and on
bone resorption. However, there are also evidence for a direct effect
of Si on osteoclasts. We have previously, in 2014, reported that Si
inhibits bone resorption in vitro and dose-dependently reduced the
number of TRAP+ multinucleated cells that were differentiated from
bone marrow cultures and cultures of RAW264.7 cells.22 This
inhibitory effect of Si on osteoclastogenesis has been confirmed by
others, in stimulated hCD14+ osteoclast precursors and in mouse
bone marrow macrophages.24,28 However, mechanisms have not been
established. It is also not known at what stage(s) of osteoclastogenesis
Si acts on to inhibit osteoclast differentiation. Moreover, it is not clear
which form of Si (soluble, polymeric/particulate, or both) is responsi-
ble for the inhibitory effect. Beck et al., reported their findings of stim-
ulative effects on osteoblast differentiation and suppressive effects
on osteoclast differentiation using engineered nano-particulate silica
(50 nm).29 However, most studies report using soluble Si (silicic acid
or OSA), but provide only brief details of their preparation and no
characterisation of the Si treatment solution.22,24,28 Those with
knowledge of aqueous Si chemistry will acknowledge its complexity
and that transient polymeric/particulate Si species can readily and
easily be formed, especially in tissue culture media, when the soluble,
and biologically relevant, OSA specie is intended.
The aims of the present study were to (a) further investigate the
direct inhibitory effects of Si on osteoclastogenesis, (b) specifically
determine at what stage in the osteoclastogenesis Si acts on, and (c)
determine whether it is soluble or particulate Si that is responsible for
the inhibitory effects. In the present study, we used RAW264.7 cells,
an established cell line that does not require co-culture with mesen-
chymal/osteoblast cells for osteoclast formation.30,31 RANKL was
used to stimulate osteoclastogenesis in RAW264.7 cells and this was
confirmed by the expression of osteoclast markers (RANK, TRAP, CtsK,
and CalcR).
2 | MATERIAL AND METHODS
2.1 | Si-supplemented cell culture medium
2.1.1 | Preparation of Si-supplemented cell culture
medium
Standard preparation of the Si-supplemented cell culture medium was
according to previously published protocol.22,32 Briefly, a stock
350 μg/ml Si solution was prepared by adding 100 μl of concentrated
basic sodium silicate solution (reagent grade, Sigma-Aldrich, St. Louis,
MO) to 49.9 ml minimum essential medium α (α-MEM; Gibco, Thermo-
Fisher, Waltham, MA) supplemented with 1% antibiotic–antimycotic
(Anti-Anti; Gibco, ThermoFisher, Waltham, MA) and 1% L-alanyl-L-
glutamine (GlutaMAX; Gibco, ThermoFisher, Waltham, MA). The pH
was immediately adjusted to 7.0–7.2 with concentrated HCl (ACS
reagent 37%, Sigma-Aldrich, St. Louis, MO) and then supplemented
with 10% (v/v) fetal bovine serum (FBS; Gibco, ThermoFisher, Wal-
tham, MA). This stock Si solution was then immediately diluted (within
10 min of preparation) in cell culture media (α-MEM supplemented with
antibiotic/antimycotic, glutamine and 10% FBS) to the desired Si con-
centrations (25–150 μg/ml Si) and left to stand for 24 hr before addi-
tion to the cell cultures.
In order to obtain a higher fraction of soluble Si (OSA) in the Si-
supplemented cell culture medium, the above protocol was modified.
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As above, a 350 μg/ml Si stock was prepared by adding 100 μl of con-
centrated basic sodium silicate solution to 49.9 ml α-MEM (with 1%
antibiotic–antimycotic and 1% L-alanyl-L-glutamine), but after
through mixing and without pH-adjustment or addition of FBS, was
diluted in α-MEM (supplemented with antibiotic/antimycotic and glu-
tamine) to the desired Si concentrations (25–150 μg/ml Si) and stored
at room temperature for 24 hr. Thereafter, the pH was corrected to
7.0–7.2 with HCl and the medium was stored for another 48 hr at
room temperature. Finally, 10% FBS (v/v) was supplemented into the
medium just before addition to the cell cultures.
2.1.2 | Analyses of Si species in cell culture
medium
Aliquots of the standard preparations of the Si stock solution
(350 μg/ml) and 50 μg/ml dilution were analysed for nano-
particulate silica content by dynamic light scattering (DLS). DLS
measurements were performed at room temperature, with polysty-
rene micro-cuvettes using a Zetasizer Nano-ZS (Malvern Instru-
ments Ltd, Malvern, UK). Since FBS interfered with the DLS
measurement, the 350 μg/ml stock solution and 50 μg/ml dilution
were prepared without FBS. Acquisition parameters for silicon
dioxide (refractive index = 1.45, absorption = 0.01) were used,
along with a 173 backscatter angle. For each sample, three repli-
cate of 15 measurements were recorded and the average volume
particle distribution reported.
Aliquots of the standard prep of the 350 μg/ml Si stock solution
and 50 μg/ml dilution and the modified 50 μg/ml Si prep underwent
ultrafiltration and total element analysis by inductive coupled plasma–
optical emission spectroscopy (ICP–OES) to determine the fraction of
soluble and particulate Si in these preparations. Briefly, 500 μl aliquots
of the solutions were ultra-filtered using Vivaspin-500 centrifuge
units with 3,000 MWCO membrane, at 13,000 rpm for 5 min in an
Eppendorf 5804R centrifuge. The ultra-filtrate and the fraction
retained by the membrane were collected and diluted with UHP water
and analysed for Si content by ICP–OES as described below. To deter-
mine possible Si contamination of the sample from the ultra-filter
units, four aliquots of UHP water was similar processed and analysed
for Si content. Aliquots of the unfiltered Si solutions were also
analysed by ICP–OES to determine total Si content.
Total elemental analysis for Si by ICP–OES was carried out on a
Jobin Yvon Horiba Ultima 2C (Instrument SA, Longjumeau, France),
equipped with a concentric nebuliser and cyclonic spray chamber. A
sample introduction pump speed of 15 rpm, nebuliser flow rate of
0.45 L/min and a plasma gas flow rate of 10 L/min were used. Peak
profiles were used as previously described,33 with a window size of
0.075 nm (0.0375 nm either side of the peak) with 21 increments per
profile and an integration time of 0.5 s per increment. The
251.611 nm analytical line for Si was used. Samples were analysed
with Si standards (0–20 mg/L) prepared in diluted α-MEM, using a
1,000 mg/L Si ICP solution. Each sample/standard was analysed in
triplicate and the average value used for calculations.
2.2 | Cell culturing
RAW264.7 cells (ATCC TIB-71, USA), were maintained in α-MEM sup-
plemented with 1% antibiotic–antimycotic, 1% L-alanyl-L-glutamine and
10% (v/v) FBS at 37C in a humidified atmosphere of 5% CO2. Cell pas-
sages between three and seven were used in the experiments described
herein. Mycoplasma tests were performed regularly in order to control
for contamination.
For experiments, cells were seeded into 24 or 96 well plates
(Nunc, ThermoFisher, Waltham, MA) with the α-MEM culture
media. After 24 hr, to allow for cell attachment, non-adherent
cells were removed and adherent cells incubated with the Si-
supplemented medium (prepared as described in Section 2.1) for
48 or 96 hr, with medium change every 48 hr. RANKL (5 ng/ml; E-
coli expressed recombinant mouse RANKL, R&D Systems, Minne-
apolis, MN) was added to the cell culture medium when investigat-
ing osteoclast differentiation.
2.3 | Effect of Si on cell viability using the neutral
red assay
The neutral red (NR) uptake assay, as described by Repetto et al.,34
was used to assess the effects of Si on cell viability. RAW264.7 cells
were cultured in 96-well plates (104 cells per well) for 24 hr with stan-
dard or modified preparations of the Si-supplemented cell culture
medium (0–150 μg/ml Si) and with or without RANKL (5 ng/ml). NR
incubation medium (40 μg/ml) was prepared by dissolving the NR dye
(Merck, Germany) in phosphate buffered saline (PBS; Gibco, Thermo-
Fisher, Waltham, MA) to 4 mg/ml and then diluted 1:100 in α-MEM.
The NR incubation medium was incubated at 37C for 24 hr and then
centrifuged for 10 min at 600 × g to remove precipitated dye crystals.
Cells were incubated with NR medium (100 μl per well) at 37C for
2 hr, then washed with PBS (150 μl per well). NR destain solution
(50% EtOH-96%, 49% deionised water and 1% acetic acid) was added
(150 μl per well) and the plates were shaken for 10 min to release the
NR dye from the cell lysosomes. The amount of viable cells was quan-
tified by measuring the absorbance of the released NR dye at 540 nm
on an optical microplate reader (Multiskan FC, ThermoScientific, Wal-
tham, MA). The experiment was repeated three times with eight repli-
cates per treatment.
2.4 | Effect of Si on osteoclastogenesis
RAW264.7 cells were cultured in 24-well plates (5 × 103 cells per
well) with or without RANKL (5 ng/ml) for 48/96 hr. Silicon (50 μg/ml)
was also present either for the entire 48/96 hr period or for shorter
durations (0–24, 0–48, and 0–72 hr) or added at different 24 hr inter-
vals over the 96 hr (24–48, 48–72, and 72–96 hr). Following incuba-
tion with Si-supplemented media, cells were washed twice with PBS
(500 μl per well) and cultured for the remaining period in α-MEM with
RANKL (5 ng/ml). Cells were then stained for TRAP to identify
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multinucleated osteoclast-like cells or the RNA extracted and assessed
by RT-qPCR for phenotypic markers of osteoclast differentiation (see
below). The experiment was repeated three times with four replicates
per treatment.
2.4.1 | TRAP-staining of osteoclast-like cells
After 96 hr and after washing with PBS (2 × 500 μl per well), cells
were fixed with citrate-acetone (500 μl per well with a solution con-
taining 27% 27 mM Citrate solution and 73% of a 2.5 M Acetate
solution) for 30 s and air-dried at room temperature. Cells were sta-
ined for tartrate-resistant acid phosphatase (TRAP) using a commer-
cially available kit (Acid Phosphatase Leukocyte staining kit, Sigma-
Aldrich, St. Louis, MO) and following the manufacturer's protocol but
with a reduced staining time of 20 min. Cells stained dark red with
three or more nuclei were counted as osteoclasts. Images were cap-
tured with a Zeiss Primo Vert light microscope under ×5
magnification.
2.4.2 | Relative quantification of gene expression
analysis by RT-qPCR
The minimum information for publication of quantitative real-time
PCR experiments (MIQE) guidelines checklist was followed to ensure
the relevant experimental conditions and assay characteristics.35
Total RNA was extracted from the cell lysate with the RNeasy
Mini Kit (Qiagen, Germany) according to manufacturer's protocol.
Briefly, cell culture medium was removed and cells were washed
with PBS, then lysed and homogenised. The cell lysates were cen-
trifuged through a gDNA eliminator spin column. Ethanol (70%)
were then added to the flow through making the RNA bind to the
membrane in the spin column and the columns were repeatedly
rinsed and washed with several buffers. The purified RNA were
eluted in 80 μl of RNase free water. RNA concentration was quanti-
fied with the Qubit RNA broad range assay kit and Qubit fluorome-
ter (Invitrogen, ThermoFisher, Waltham, MA). RNA quality was
assessed using RNA StdSens Analysis chip by Experion (Bio-Rad
Laboratories, Hercules, CA). RNA were kept at −80C until reverse
F IGURE 1 Soluble and particulate Si in the Si-supplemented cell culture medium. (a) Particle size distribution by dynamic light scattering and
(b) ultrafiltration analysis of the standard preparation of the 350 μg/ml Si stock immediately after preparation and at the point of dilution to lower
Si concentrations in cell culture medium. The fraction of ultrafilterable (<3 kDa, soluble) , recovered (>3 kDa, particulate) and unrecovered Si ,
are shown. Ultrafiltration analysis of the 50 μg/ml Si-supplemented cell culture medium immediately after preparation from the 350 μg/ml stock
(c) and after 24 hr standing and at the point of addition to the cells (d). Ultrafiltration analysis of the modified preparation of the 50 μg/ml Si-
supplemented medium, at the point of addition to cells (e). Silicon supplemented cell culture medium were prepared as described in Materials and
Methods. Data are presented as mean ± SEM of at least three independent preparations (N = 3) except for 350 μg/ml Si stock (one preparation
analysed in triplicates by ultrafiltration). Significant differences in percentage ultrafilterable Si between the two different 50 μg/ml Si preps and
between the different times points after prep are shown: (p < .001)***
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transcription (RT). RT was performed on a MiniOpticon (Bio-Rad
Laboratories, Hercules, CA) using iScript gDNA Clear cDNA Syn-
thesis kit (Bio-Rad Laboratories, USA) with 0.1 μg total RNA in
20 μl reaction volumes. Identification of any possible inhibition in
the RT and the subsequent RT-qPCR assay, was controlled by
adding 0.01 ng of Universal RNA Spike template (TATAA Biocenter,
Sweden) to each RT reaction.
To compensate for possible variation in the amount of genetic
material, the target gene expression was normalised towards a
selected reference gene with a constant and non-regulated expres-
sion. The most stable reference gene for RAW264.7 cells was selected
by screening 12 potential reference genes (mouse Reference gene
panel, TATAA Biocenter, Sweden) on the different samples in the
experiment.36 Analysis of the expressions by geNorm and Normfinder
algorithms (GenEx software, Multid Analyses, Sweden) showed that
the most stable reference genes were peptidylpropyl isomerase A
(PPIA) and TATA-box binding protein (TBP).
Gene expression analysis was assessed using SsoAdvanced Uni-
versal SYBR Green Supermix (Bio-Rad Laboratories, Hercules, CA)
and wet lab validated predesigned primers (Bio-Rad Laboratories,
Hercules, CA). The primer assay identification numbers were Recep-
tor Activator of Nuclear Factor K-B (RANK) (qMmuCED0046133),
Nuclear Factor of Activated T-cell 1 (NFATc1) (qMmuCID0040129),
Dendritic Cell Specific Transmembrane Protein (DC-STAMP)
(qMmuCID0019866), Calcitonin Receptor (CalcR) (qMmuCID0021168),
Cathepsin K (CtsK) (qMmuCID0022824), Tartrate Resistant Acid
Phosphatase (TRAP) (qMmuCED0044793), TATA-box Binding Pro-
tein (TBP) (qMmuCID0040542), and Peptidylprolyl Isomeras A (PPIA)
(qMmuCED0041303). The expression of the target genes and the
two reference genes were analysed with 1 ng cDNA in a 10 μl reac-
tion volume in duplicates on a CFX Connect Real-Time System with
the CFX manager software (Bio-Rad Laboratories, Hercules, CA). As
all the samples did not fit in one PCR plate layout, an interplate
calibrator (TATAA Biocenter, Sweden) was added in triplicates to
each PCR plate to compensate for variations between qPCR runs.
Melting curves for each reaction were performed between 60 and
95C to detect any primer dimers. The qPCR results were normalised
to PPIA and TBP and compared to positive control (RANKL). As all
assays had 90–100% efficiency, 2-ΔΔCq was used to calculate the rel-
ative gene expression.
2.5 | Statistics
Results are reported as means ± SEM unless otherwise stated. Normal
distribution of the data was confirmed with the Shapiro–Wilk normal-
ity test. One-way ANOVA followed by Tukey's multiple comparisons
test was used to compare between treatments and significance was
taken when p < .05. All statistical analyses were performed in Gra-
phPad PRISM 7 (GraphPad Software). In the figures, statistical signifi-
cance was denoted as: *p < .05, **p < .01, and ***p < .001.
3 | RESULTS
3.1 | Characterisation of Si-supplemented cell
culture medium
Standard preparation of Si-supplemented cell culture media were pre-
pared as previously described22 and Si concentrations of the 350 μg
Si/ml stock solution and 50 μg/ml dilution were verified by ICP–OES;
mean values were 375 ± 12.6 (SD) and 52.5 ± 1.2 (SD) μg Si/ml
respectively (N ≥ 3). Particle sizing, by DLS, of the 350 μg Si/ml stock
immediately after preparation and at the time of dilution to lower Si
concentrations, showed the presence of particles between 1.5 and
7.5 nm in diameter (median particle diameter of 2.7 nm, Figure 1a).
F IGURE 2 Soluble and particulate Si in the 50 μg/ml Si-supplemented cell culture medium under cell incubating conditions (37C
and 5% CO2). Ultrafiltration analysis of the (a) standard (partly soluble) and (b) modified (highly soluble) preparations of the 50 μg/ml
Si-supplemented media following incubation under cell culture conditions for 4–72 hr. The fraction of ultrafilterable (<3 kDa, soluble)
and recovered (>3 kDa, particulate) Si is shown. Data is mean ± SEM of three independent preparations of the 50 μg/ml Si-supplemented
cell culture medium (N = 3)
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TEM, 29Si-NMR and zeta potential analyses of similar size Si particles,
prepared from the same source (alkaline sodium silicate) and the same
methodology/protocol has been previously described by us.37,38 Note
the 350 μg Si/ml stock is meta-stable since the particles doubled in
size with every hour of standing after preparation (Figure S1). Particle
sizing could not be carried out on the 50 μg/ml Si-supplemented
media due to the low particle count. Therefore, ultrafiltration studies
were performed to determine the fractions of soluble (ultrafilterable,
< 3,000 MWCO) and particulate Si. The 350 μg Si/ml stock solution,
immediately after preparation and at the time of dilution to lower Si
concentrations, contained 7% ultrafilterable (soluble) Si (Figure 1b).
The 50 μg/ml Si-supplemented media similarly contained 10% ultra-
filterable Si immediately after preparation from the 350 μg/ml stock
(Figure 1c), and on standing for 24 hr and just prior addition to cells,
the amount of ultrafilterable Si in 50 μg/ml Si-supplemented media
increased to 28% (Figure 1d; p < .001). To increase the proportion of
ultrafilterable (soluble) Si in the Si-supplemented media, the method
of preparation was modified, as described in Methods. Ultrafiltration
study showed that the modified preparation of the 50 μg/ml Si-
supplemented media contained 74% ultrafilterable Si at the time of
addition to the cells (Figure 1e), significantly more than in the standard
preparation (p < .001). To distinguish between the two different prep-
arations of the Si-supplemented media and their content of soluble Si,
we use the term “Standard (partly soluble) Si prep” and “Modified
(highly soluble) Si prep” in the text.
To investigate how the proportions of ultrafilterable (soluble) Si
changes in the 50 μg/ml Si-supplemented media under cell culturing
conditions, that is, 37C and 5% CO2, further ultrafiltration analysis
were performed. Aliquots of the 50 μg/ml Si-supplemented media
were incubated at 37C and 5% CO2 for different durations (4–
72 hr) prior to ultrafiltration analysis. As shown in Figure 2, after 4 hr
of incubation under cell culture conditions the proportion of ultra-
filterable (soluble) Si in the standard (partly soluble) prep of the
50 μg/ml Si-supplemented media had increased to 74% (Figure 2a),
markedly more than at the time of addition to the cells (Figure 1d),
and maintained this level of soluble Si for the entire 72 hr. These
levels of soluble Si were slightly lower, but comparable to that seen
in the modified (highly soluble) prep of the 50 μg/ml Si-
F IGURE 3 Effects of Si on Neutral Red uptake in RAW264.7 cells. Neutral Red uptake was used to assess cell viability/proliferation in
RAW264.7 cells 24 hr after culturing with either standard (partly soluble) (a and b) or modified (highly soluble) (c and d) preparations of the Si-
supplemented cell culture medium and with (b and d) or without (a and c) RANKL (5 ng/ml). Silicon concentration span 0–150 μg/ml. Data are
presented as mean percentage of control ± SEM of eight samples from a representative experiment (N = 8), with the control set to 100%.
Significant differences compared to control are shown: (p < .001)***
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supplemented media investigated under the same conditions
(Figure 2b).
3.2 | Effects of Si on neutral red uptake
Neutral Red (NR) uptake by RAW264.7 cells was assessed after 24 hr
incubation with Si (0–150 μg/ml) in the presence and absence of
RANKL (5 ng/ml). RAW264.7 cells treated with either the standard
(partly soluble) or modified (highly soluble) prep of the Si-supplemented
cell culture medium showed significantly reduced uptake of NR at Si
concentrations ≥100 μg/ml (p < .001, Figure 3). The 100 μg/ml modi-
fied (highly soluble) Si prep showed a more pronounced reduction in
NR uptake than the standard (partly soluble) Si prep. With 75 μg/ml Si,
a slight increase in NR uptake was observed with both the standard
(partly soluble) and modified (highly soluble) Si preps, whilst with
50 μg/ml Si, there was no difference in NR uptake, compared with con-
trol, with either Si preps. The 50 μg/ml Si concentration, showing no
effect on cell viability/proliferation, was therefore chosen for the fur-
ther experiments described below. RANKL had no influence on the
observed Si effects.
3.3 | Effects of Si on osteoclast formation
The effects of the standard (partly soluble) prep of the 50 μg/ml
Si-supplemented medium, added at different periods during oste-
oclast formation was investigated (Figure 4). These experiments
were carried out in the presence of RANKL as TRAP+
multinucleated cells (differentiated/mature osteoclasts) are
formed only in RANKL-stimulated cultures. Washing with PBS
(i.e., following Si incubation) did not have any effects on the num-
ber of TRAP+ multinucleated cells (data not shown). The number
of TRAP+ multinucleated cells was significantly reduced compared
with RANKL-stimulated cells (p < .001), when 50 μg/ml Si was pre-
sent for at least the first 24 hr of the 96 hr culture period
(Figure 4a,c). No further reduction in TRAP+ cells was seen with
longer periods of incubation with 50 μg/ml Si (i.e., > 0–24 hr,
Figure 4a,c). In contrast, when 50 μg/ml Si was added at any time
after the first 24 hr, no reduction in the number of TRAP+ cells
was seen (Figure 4b,c).
3.4 | Effects of Si on gene expression
The relative expression of RANK, NFATc1, DC-STAMP, TRAP, CtsK, and
CalcR in RAW264.7 cells, following incubation with or without RANKL
(for 48 or 96 hr) and with or without standard (partly soluble) prep of
the 50 μg/ml Si-supplemented medium for 0–24, 0–48, or 0–96 hr,
was assessed by RT-qPCR (Figure 5). RANK, NFATc1, and DC-STAMP
expression were detected in both control and RANKL-stimulated cells
(Figure 5a–f), with significantly highly (p < .001) expression of NFATc1
and DC-STAMP in RANKL-stimulated cells (Figure 5c–f). RANK
F IGURE 4 Effects of Si on osteoclast formation in RAW264.7
cells. RAW264.7 cells was cultured with RANKL (5 ng/ml) and with
the standard (partly soluble) Si preparation of the 50 μg/ml Si-
supplemented cell culture medium, at different time intervals and
24 hr durations over a 96 hr cell culture period. Silicon was present
for (a) increasing 24 hr durations, 0–24 hr and up to 96 hr or
(b) added at different 24 hr time intervals over the 96 hr. The number
of TRAP+ multinucleated cells are presented as mean ± SEM of four
samples from a representative experiment (N = 4). Significant
differences compared to RANKL alone are shown: (p < .001)***.
(c) Representative micrographs showing cell morphology and
distribution in the corresponding treatment groups after 96 hr culture
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expression was also significantly higher (p < .001) in RANKL-stimulated
cells (compared to unstimulated cells), but only in the 96 hr cultures
(Figure 5b). CalcR, CtsK, and TRAP were only expressed in RANKL-
stimulated cells (Figure 5g–l). Silicon (50 μg/ml) did not significantly
alter the expression of RANK and NFATc1 in either control or RANKL-
stimulated RAW264.7 cells (Figure 5a–d). However, CtsK and TRAP
expression were significantly inhibited (p < .001) when Si was present
for the entire culturing period (0–48 / 0–96 hr; Figure 5i–l). Silicon
(50 μg/ml) also significantly inhibited the expression of DC-STAMP
(p = .002) and CalcR (p < .001) in the RANKL-stimulated cells, but only
in 96 hr culture (Figure 5f,h). Furthermore, exposure of the cells to Si
over the first 24 hr of culture was sufficient to cause significant
inhibition of CtsK (p = .039), TRAP (p = .002), DC-STAMP (p = .018), and
CalcR (p < .001) in the 96 hr culture (0–24 hr; Figure 5f,h,j,l).
3.5 | Comparison of the standard (partly soluble)
and modified (highly soluble) preparations of the Si-
supplemented cell culture medium on gene expression
CtsK, TRAP, and CalcR expression, in RANKL-stimulated RAW264.7
cells, were then compared between the standard (partly soluble) and
modified (highly soluble) Si prep of the 50 μg/ml Si-supplemented
media. The modified (highly soluble) prep of the 50 μg/ml Si-
F IGURE 5 Effects of Si on gene expressions in RAW264.7 cells. Expression of RANK, NFATc1, DC-STAMP, CalcR, CtsK, and TRAP genes
in RAW264.7 cells cultured with the standard (partly soluble) preparation of the 50 μg/ml Si-supplemented cell culture medium for 48 hr (a, c, e,
g, i, and k) or 96 hr (b, d, f, h, j, and l), with or without RANKL (5 ng/ml). Gene expressions are normalised to TBP and PPIA. Values are presented
as mean fold changes relative to RANKL ± SEM of four samples from two representative experiment (N = 6–8). Significant differences are shown:
(p < .05)*, (p < .01)**, (p < .001)***
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supplemented cell culture medium significantly inhibited CtsK expres-
sion (p = .041), to the same extent as the standard (partly soluble) Si
prep (p = .019; Figure 6a). Similarly, TRAP and CalcR expressions were
also significantly supressed, by the same extent, with both the modified
(highly soluble) and standard (partly soluble) preparation of the 50 μg/
ml Si-supplemented media (p < .001; Figure 6b,c). There was no signifi-
cant difference in the extent of inhibition of CtsK, TRAP, and CalcR
expression between the modified (highly soluble) and standard (partly
soluble) preparations of the 50 μg/ml Si-supplemented media.
4 | DISCUSSION
Silicon is a constituent of the human body, at comparable level to
iron and zinc, but very little is known about its physiological role and
therefore its clinical importance.14,39 Silicon is present in all tissues
of the rat and highest levels are found in bone and other connective
tissues.40,41 Levels in human bone and connective tissues have not
been established, although similar levels to rats are expected. The
bioavailable form of Si in the diet is the soluble OSA specie and the
same species is found in human blood. The Si specie that acts on and
accumulates in bone and other connective tissues has not been
established, but modelling studies suggest that, at least in bone, it is
likely to be OSA, in a deprotonated form.42 Soluble Si (OSA) is there-
fore considered as the biologically relevant Si specie. OSA is the pre-
dominant form of Si in aqueous solutions at neutral pH and at Si
concentrations <56 μg/ml (2 mM).11 At concentrations >56 μg/ml,
OSA starts to polymerise (auto condense) to form polymers that
have reduced solubility and hence bioavailability.11 Both the stan-
dard (partly soluble) and modified (highly soluble) preparations of the
F IGURE 5 (Continued)
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50 μg/ml Si-supplemented cell culture medium, used in the present
study, are in the pH and concentration range for OSA to be the dom-
inant specie. However, the proportion of OSA at time of addition to
the cells differed between the two solutions and was dependent on
the method of preparation. The modified (highly soluble) preparation
contained significantly higher levels of OSA at the time of addition
to the cells. Serum, which is present in the cell culture medium con-
tains proteins that may aggregate Si and/or slow down the dissolu-
tion of particulate Si to OSA. Thus, on dilution (to below 56 μg/ml Si)
the solution will require a longer period of incubation for equilibrium
between particulate and soluble Si to be reached. In the modified
(highly soluble) Si preparation, serum was only added after dilution
to 50 μg/ml and only after allowing time for any particulate Si, pre-
sent in the 350 μg/ml stock, to dissolve. Additionally, the pH (9.5–
10) of the 350 μg/ml Si stock used for the modified (highly soluble)
Si prep was not neutralised, nor was serum added, again to limit par-
ticulate Si formation, in contrast to the standard (partly soluble) prep.
However, following incubation of the standard (partly soluble)
50 μg/ml Si-supplemented media at 37C and 5% CO2, to mimic the
cell culture conditions, a marked increase in the proportion soluble Si
was observed. The levels of soluble Si was comparable to that seen
in the modified (highly soluble) prep of the 50 μg/ml Si-
supplemented media. This implies that cell culture conditions accel-
erates the dissolution of the particles in the standard (partly soluble)
prep of the 50 μg/ml Si-supplemented media and equilibrium is
attained earlier. These findings can explain the comparable cellular
results obtained with the two different 50 μg/ml Si preparations. In
contrast to the present study, most reports on the biological effects
of Si in vitro present no speciation of the Si culture medium and
therefore the active Si specie in these reports is either not known or
implied to be OSA.
Some reports suggest that human skin epithelial cells and T cells
can readily take up small amorphous silica polymers (nanoparticles) in
the culture medium,38,43 which then undergoes intracellular dissolution
releasing OSA at a faster rate than uptake of OSA from the cell
medium.43 Similar effects of silica nanoparticles on osteoblast cells have
been reported.29 It is not known if RAW264.7 cells are capable of
phagocytosing silica particles and if this could contribute to the inhibi-
tory effect of OSA on osteoclastogenesis. However, the fact that the
modified prep, which contained predominantly soluble Si with very little
particulate Si, produced the same effects as the standard (partly soluble)
prep of the Si-supplemented cell culture media, strongly suggest that
OSA is the biologically active Si specie and the ultrafiltration studies
conducted here provides the evidence for this conclusion.
In accordance with our previous study, 50 μg/ml Si did not affect
the viability of RAW264.7 cells but reduced the number of TRAP+
osteoclast-like cells in the RANKL-stimulated cultures.22 This con-
firmed that Si supresses osteoclastogenesis. Here we investigated at
what stage(s) of osteoclast differentiation Si acts upon.
Osteoclastogenesis consists of several steps, including differentiation
and fusion of mononuclear precursor cells into multinucleated osteo-
clasts.44-47 Interestingly, the presence of Si during the first 24 hr of
the RANKL-stimulated cultures reduced the number of multinucleated
TRAP+ cells to the same extent as when Si was present for the entire
96 hr incubation period. In contrast, when Si was present after the
first 24 hr period, no suppression in TRAP+ cells was seen. This
F IGURE 6 Comparison of the standard and modified Si preparations
on gene expressions in RAW264.7 cells. Expression of Cathepsin K, TRAP
and Calcitonin receptor genes by RAW264.7 cells after 96 hr culture in
either the standard (partly soluble) or modified (highly soluble)
preparations of the 50 μg/ml Si-supplemented cell culture medium, in the
presence of RANKL (5 ng/ml). Gene expression are normalised to TBP
and PPIA and presented as mean fold changes relative to RANKL ± SEM
of four samples from a representative experiment (N = 4). Significant
differences compared to RANKL are shown: (p < .05)*, (p < .001)***
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strongly suggests that Si acts upon the initial regulatory steps in
osteoclastogenesis. To investigate this further, the effects of Si on
gene expression of some characteristic osteoclast markers was
assessed. In RAW264.7 cells, osteoclastogenesis is initiated by the
binding of RANKL to the RANK receptor.45 The activation of RANK
leads to a signalling cascade that activates crucial transcription factors
such as NFATc1, which in turn induces the expression of several oste-
oclast specific genes.48 In our study, the expression of both RANK and
NFATc1 were unaffected by Si, but DC-STAMP, CalcR, CtsK, and TRAP
were clearly inhibited. DC-STAMP is a transmembrane protein that is
essential for the fusion of osteoclast progenitors.49 In DC-STAMP−/−
mice, multinucleation is abolished as shown by the lack of TRAP+
multinucleated cells.49 Similarly, in the present study, the expression
of both DC-STAMP and TRAP were suppressed and a decrease in the
number of multinucleated TRAP+ cells was seen in the Si treated cul-
tures. Interestingly, Si exposure for just the first 24 hr supressed DC-
STAMP expression to the same extent as Si exposure over the entire
96 hr. The terminal differentiated osteoclast is characterised by the
expression of phenotypic markers such as CalcR, CtsK, and TRAP.30
Here, in addition to a decrease in the number of TRAP+
multinucleated cells, the expression of CalcR, CtsK, and TRAP were
also significantly inhibited. The standard (partly soluble) and modified
(highly soluble) 50 μg/ml Si preparations inhibited these genes by
comparable amounts. Our study clearly shows that Si may have a
direct inhibitory effect on osteoclastogenesis that does not require
mediation via stromal/osteoblast cells.
In conclusion, the results from the present study confirms the
direct inhibitory effects of Si on osteoclastogenesis. Our findings sug-
gest that inhibition by Si occurs in the early stages of osteoclast differ-
entiation. Moreover, we can confidently attribute these findings to
the biologically relevant soluble Si specie (OSA).
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